(Q44120318)

30 November 2017

Molecular and enzymatic characterisation of Schistosoma mansoni thioredoxin (English)

1 reference

30 November 2017

0 references

Heather M Alger

1

1 reference

30 November 2017

Ahmed A Sayed

series ordinal

2

1 reference

30 November 2017

Miguel J Stadecker

series ordinal

3

1 reference

30 November 2017

David L Williams

series ordinal

4

1 reference

30 November 2017

1 September 2002

1 reference

International Journal for Parasitology

30 November 2017

1 reference

30 November 2017

32

1 reference

30 November 2017

10

1 reference

30 November 2017

1285-1292

1 reference

Pre- and post-treatment immunodiagnostic evaluation in human schistosomiasis mansoni

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Preparation and assay of mammalian thioredoxin and thioredoxin reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

The schistosome egg: development and secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Cultivation of Schistosoma mansoni In vitro. I. Establishment of Cultures from Cercariae and Development until Pairing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Rats, mice and men - models for immune effector mechanisms against schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Does the immunopathology induced by schistosome eggs potentiate parasite survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

An Improved Perfusion Technique for Recovering Adult Schistosomes from Laboratory Animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Immunopathology of murine infection with Schistosoma mansoni: relationship of genetic background to hepatosplenic disease and modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin peroxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Do antioxidants play a role in schistosome host-parasite interactions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Peroxidoxins: a new antioxidant family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Antioxidant systems in Schistosoma mansoni: correlation between susceptibility to oxidant killing and the levels of scavengers of hydrogen peroxide and oxygen free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Anti-egg precipitins in the serum of humans infected with Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Properties and biological activities of thioredoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Fasciola hepatica: heterologous expression and functional characterization of a thioredoxin peroxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Heterologous expression and functional characterization of thioredoxin from Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Control of schistosomiasis--a global picture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Bovine T cell responses to recombinant thioredoxin of Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

The identification and characterization of new immunogenic egg components: implications for evaluation and control of the immunopathogenic T cell response in schistosomiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Thioredoxin reductase two modes of catalysis have evolved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

Schistosome infection stimulates host CD4(+) T helper cell and B-cell responses against a novel egg antigen, thioredoxin peroxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2802%2900108-X

10.1016/S0020-7519(02)00108-X

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference